2023 Form 5500 filing — Forma Therapeutics, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240229135944NAL0008111571001) for Forma Therapeutics, Inc. 401(K) Plan, reported by Forma Therapeutics, Inc. under EIN 26-0428600 and plan number 001. It reports 238 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).

EFAST2 acknowledgement
20240229135944NAL0008111571001
Filing year
2023
Form type
2
Plan sponsor
Forma Therapeutics, Inc.
EIN
26-0428600
Plan number
001
Location
Watertown, MA
Participants
238
Schedules available
Schedule H, Schedule C
Received date
not reported in the loaded dataset

Reported financial snapshot (2023)

Total assets (EOY)
$0
Total liabilities (EOY)
$0
Net assets (EOY)
$0
Total income / additions
$1,367,600
Benefits paid
$24,969,421
Administrative expenses
$32,237
Total expenses
$25,001,658
Net increase / (decrease)
-$23,634,058
Schedule source
Schedule H

Reported service provider compensation (Schedule C)

Compensation reported on the 2023 filing
ProviderServiceDirect comp.Indirect comp.
Alerus Financial, N.A.NONE$25,422$0
Icapital, LLCNONE$6,815not reported in the loaded dataset

Related Form 5500 pages